The expression and significance of semaphoring 3A in the serum and peripheral blood mononuclear cell of the patients with rheumatoid arthritis
Xiao-xu MA,Fan-lei HU,Lian-jie SHI,Ying-ni LI,Yan DU,Chun LI,Li ZHENG,Xue-wu ZHANG
DOI: https://doi.org/10.3969/j.issn.2095-252X.2013.07.003
2013-01-01
Abstract: Objective To investigate the function of semaphoring 3A ( Sema 3A ) in the pathogenesis of rheumatoid arthritis ( RA ) through analyzing the expression level of Sema 3A in the peripheral blood mononuclear cell ( PBMC ) and serum of the patients with RA. Methods ( 1 ) The concentration of Sema 3A in the serum was detected by the enzyme-linked immuno sorbent assay ( ELISA ) in 130 patients with RA, 165 patients with other rheumatic diseases and 150 healthy controls. And meanwhile, its correlation with the clinical and laboratory indexes of the patients with RA was analyzed. ( 2 ) In addition, the message ribonucleic acid ( mRNA ) expression level of Sema 3A in the PBMC from 45 patients with RA and 35 healthy controls was detected by the real-time quantitative polymerase chain reaction ( PCR ). Results The concentration of Sema 3A in the serum of the patients with RA ( 15.89±8.58 ) ng/ml was significantly higher than that of the healthy controls ( 6.96±2.62 ) ng/ml, ( P<0.01 ) and that of the patients with other rheumatic diseases ( 4.35±3.57 ) ng/ml, ( P<0.01 ). The mRNA expression level of Sema 3A in the PBMC of the patients with RA was ( 1.83±1.47 ), which was significantly higher than ( 1.01±0.85 ) of the healthy controls ( P<0.01 ). There was a positive correlation of the concentration of Sema 3A in the serum and the platelet count ( r=0.229, P<0.01 ), erythrocyte sedimentation rate ( ESR ) ( r=0.174, P<0.05 ), immunoglobulin M ( IgM ) ( r=0.254, P<0.01 ), rheumatoid factor ( RF ) ( r=0.299, P<0.01 ) and histamine-releasing factor-immunoglobulin G ( HRF-IgG ) ( r=0.203, P<0.05 ). In addition, the concentration of Sema 3A in the serum of the RF-, HRF-IgG-, animal protein factor ( APF )-, anti-keratin antibody ( AKA )-, anti-cyclic citrullinated peptide ( CCP ) antibody-positive patients with RA was significantly greater than that of the RF-, HRF-IgG-, APF-, AKA-, anti-CCP antibody-negative patients ( P<0.05 ). Conclusions The expression level of Sema 3A in the serum and PBMC is significantly elevated in the patients with RA, which is closely correlated with the RA disease activity. It is indicated that Sema 3A may become a potentially new target in the treatment of RA.